ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166237; 2) Community: the network communities that were significantly associated with the response to NSC 166237; 3) Molecule: the relationships between components within communities and NSC 166237; 4) MDR: the compounds that were significantly associated with the NSC 166237.

NSC Compound Enrichment Correlation
NSC 633530 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- 0.0459335986102865 -0.01087247
NSC 635544 Null 0.0459335986102865 -0.11053006
NSC 643740 Null 0.0459335986102865 0.14270464
NSC 643828 9-Aza-3,5-dioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy- 7-methoxy-9,N,N,N-tetramethyl-, inner salt,4-oxide 0.0459335986102865 0.19777314
NSC 655438 Null 0.0459335986102865 0.25754337
NSC 66214 4-Amino-1-dodecylquinaldinium acetate 0.0459335986102865 0.13457186
NSC 668331 Null 0.0459335986102865 0.20350823
NSC 671311 Null 0.0459335986102865 0.35968643
NSC 674098 2-Acetylimidazo[4,5-b]pyridin 4 sec-butyl 3thiosemi-carbazone 0.0459335986102865 0.24569547
NSC 681637 Camptothecin Derivative 0.0459335986102865 0.5690965
Total:64  Current:58    [First] [Prev] [Next] [Last]